Palliative radiation therapy in the management of brain metastases, spinal cord compression, and bone metastases

Seminars in Interventional Radiology

Volumn 24, Issue 4, 2007, Pages 363-374

  Sejpal, Samir V ^a   Bhate, Amit ^a   Small Jr , William ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bone metastases; Brain metastases; Palliative care; Spinal cord compression; Whole brain radiotherapy

Indexed keywords

RADIOISOTOPE; SAMARIUM 153; STRONTIUM 89;

BLEEDING; BONE METASTASIS; BRAIN METASTASIS; BRAIN SURGERY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; EXTERNAL BEAM RADIOTHERAPY; FRACTIONATION; HUMAN; LAMINECTOMY; ORTHOPEDIC SURGERY; PALLIATIVE THERAPY; PATIENT CARE; PROGNOSIS; RADIATION DOSE; REVIEW; SPINAL CORD COMPRESSION; STEREOTAXIC SURGERY; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 37149034372     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-992324     Document Type: Review

References (52)

1. Kirkbride P, Bezjak A. Therapies with palliative intent. In: Berger AM, Portenoy RK, Weissman DE, eds. Principles and Practice of Palliative Care and Supportive Oncology. Philadelphia: Lippincott Williams & Wilkins; 1998:685-697
2. Barnes EA, Palmer JL, Bruera E. Prevalence of symptom control and palliative care. Abstracts presented at the annual meeting of the American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 2002;54:211-214
3. Nielsen OS. Present status of palliative radiotherapy. Eur J Cancer 2001;37(suppl 7):S279-S288
4. Tsao MN, Lloyd NS, Wong RK, et al. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 2005;31:256-273
5. Khuntia D, Brown P, Li J, et al. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 2006;24:1295-1304
6. Tham YL, Sexton K, Kramer R, et al. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 2006;107:696-704
7. Slimane K, Andre F, Delaloge S, et al. Risk factors for brain relapse in patients with metastatic breast cancer. Ann Oncol 2004;15:1640-1644
8. Miller KD, Weathers T, Haney LG, et al. Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival. Ann Oncol 2003;14:1072-1077
9. Porter AT, David M. Palliative care for bone, spinal cord, brain and liver metastases. In: Gunderson LL, Tepper JE, eds. Clinical Radiation Oncology. Philadelphia: Elsevier; 2007:437-455
10. Narayana A, Liebel SA. Primary and metastatic brain tumors. In: Liebel SA, Phillips TL, eds. Textbook of Radiation Oncology. Philadelphia: Elsevier; 2004:463-495
11. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-751
12. Sneed PK, Larson DA, Wara WM. Radiotherapy for cerebral metastases. Neurosurg Clin N Am 1996;7:505-515
13. Cairncross JG, Kim JH, Posner JB. Radiation therapy for brain metastases. Ann Neurol 1980;7:529-541
14. Nieder C, Berberich W, Schnabel K. Tumor-related prognostic factors for remission of brain metastases after radiotherapy. Int J Radiat Oncol Biol Phys 1997;39:25-30
15. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980;6:1-9
16. Murray KJ, Scott C, Greenberg HM, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997;39:571-574
17. Komarnicky LT, Phillips TL, Martz K, et al. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 1991;20:53-58
18. Phillips TL, Scott CB, Leibel SA, et al. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys 1995;33:339-348
19. Borgelt B, Gelber R, Larson M, et al. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981;7:1633-1638
20. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500
21. Noordijk EM, Vecht CJ, Haaxma-Reiche H, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 1994;29:711-717
22. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single brain metastases to the brain. JAMA 1998;280:1485-1489
23. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 2004;363:1665-1672
24. Mehta MP, Tsao MN, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005;63:37-46
25. Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999;45:427-434
26. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295:2483-2491
27. Mehta MP, Rodrigus P, Terhaard CH, et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 2003;21:2529-2536
28. Mehta MP, Gervais R, Chabot P, et al. Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: results of a phase III trial [abstract]. J Clin Oncol 2006;24:367s
29. Stea B, Suh J, Shaw E, et al. Efaproxiral (Efaproxyn) as an adjunct to whole brain radiation therapy for the treatment of brain metastases originating from breast cancer: Updated survival results of the randomized REACH (RT-009) study. Presented at the San Antonio Breast Cancer SymposiumSan Antonio, TX: December 8-11, 2004 (Abstract 4064)
30. Antonadou D, Paraskevaidis M, Sarris G, et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002;20:3644-3650
31. Verger E, Gil M, Yaya R, et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys 2005;61:185-191
32. Rades D, Stalpers LJ, Veninga T, et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005;23:3366-3375
33. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005;366:643-648
34. Prasad D, Schiff D. Malignant spinal-cord compression. Lancet Oncol 2005;6:15-24
35. Loblaw DA, Laperriere NJ, Mackillop WJ. A population-based study of malignant spinal cord compression in Ontario. Clin Oncol (R Coll Radiol) 2003;15:211-217
36. Loblaw DA, Perry J, Chambers A, et al. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the cancer care Ontario practice guidelines initiative's neuro-oncology disease site group. J Clin Oncol 2005;23:2028-2037
37. Talcott JA, Stomper PC, Drislane FW, et al. Assessing suspected spinal cord compression: a multidisciplinary outcome analyses of 342 episodes. Support Care Cancer 1999;7:31-38
38. Young RF, Post EM, King GA. Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg 1980;53:741-748
39. Rades D, Fehlauer F, Schulte R, et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 2006;24:3388-3393
40. Maranzano E, Latini P, Beneventi S, et al. Comparison of two different radiotherapy schedules for spinal cord compression in prostate cancer. Tumori 1998;84:472-477
41. Vassiliou V, Kalogeropoulou C, Christopoulos C, et al. Combination Ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment. Int J Radiat Oncol Biol Phys 2007;67:264-272
42. Falkmer U, Jarhult J, Wersall P, et al. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol 2003;42:620-633
43. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001;27:165-176
44. Taube T, Elomaa I, Blomqvist C, et al. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone 1994;15:161-166
45. Vakaet LA, Boterberg T. Pain control by ionizing radiation of bone metastasis. Int J Dev Biol 2004;48:599-606
46. Elomaa I. Use of bisphosphonates in skeletal metastasis. Acta Oncol 2000;39:445-454
47. Berenson JR. Recommendations for zoledronic acid treatment of patient with bone metastases. Oncologist 2005;10:52-62
48. Kachnic L, Berk L. Palliative single-fraction radiation therapy: how much more evidence is needed. J Natl Cancer Inst 2005;97:786-788
49. Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short- versus long-course radiotherapy for palliation of bone metastases. J Natl Cancer Inst 2005;97:798-804
50. Steenland E, Leer JW, van Houwelingen H, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999;52:101-109
51. Bone Pain Trial Working Party. 8 Gy in single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother Oncol 1999;52:111-121
52. Poulter CA, Cosmatos D, Rubin P, et al. A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases. Int J Radiat Oncol Biol Phys 1992;23:207-214